A missing link? Monocyte activation by uremic toxins in cardiorenal syndrome

Journal of Leukocyte Biology

Volumn 93, Issue 6, 2013, Pages 821-823

  Armstrong, Ehrin J ^a   Granick, Jennifer L ^b   Simon, Scott I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Chronic kidney disease; Kremezin; Monocytes; Renal pathology

Indexed keywords

ALBUMIN; AST 120; COLLAGEN; ENDOTHELIN 1; INDICAN; INDOLE; INTERCELLULAR ADHESION MOLECULE 1; OSTEOPONTIN; SUPEROXIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRYPTOPHAN; UREMIC TOXIN; CARBON; GASTROINTESTINAL AGENT; OXIDE;

ATHEROSCLEROSIS; CARDIORENAL SYNDROME; CELL ACTIVATION; CHRONIC KIDNEY DISEASE; EDITORIAL; GLOMERULUS FILTRATION RATE; HEART MUSCLE FIBROSIS; HEMODIALYSIS; HUMAN; KIDNEY CLEARANCE; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY TUBULE; KIDNEY TUBULE CELL; LIVER CELL; LIVER CIRCULATION; MACROPHAGE; MONOCYTE; MORBIDITY; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; UPREGULATION; ANIMAL; CHRONIC KIDNEY FAILURE; INFLAMMATION; MALE; METABOLISM; NOTE; RENAL PATHOLOGY;

CHRONIC KIDNEY DISEASE; KREMEZIN; MONOCYTES; RENAL PATHOLOGY;

ANIMALS; CARBON; GASTROINTESTINAL AGENTS; HUMANS; INDICAN; INFLAMMATION; MALE; MONOCYTES; OXIDES; RENAL INSUFFICIENCY, CHRONIC;

EID: 84878391809     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0113037     Document Type: Editorial

References (10)

1. Lekawanvijit, S., Kompa, A. R., Wang, B. H., Kelly, D. J., Krum, H. (2012) Cardiorenal syndrome: the emerging role of proteinbound uremic toxins. Circ. Res. 111, 1470-1483
2. Lekawanvijit, S., Adrahtas, A., Kelly, D. J., Kompa, A. R., Wang, B. H., Krum, H. (2010) Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes? Eur. Heart J. 31, 1771-1779
3. Sun, C. Y., Hsu, H. H., Wu, M. S. (2013) p-Cresol sulfate and indoxyl sulfate induce similar cellular inflammatory gene expressions in cultured proximal renal tubular cells. Nephrol. Dial. Transplant. 28, 70-78
4. Tamada, S., Asai, T., Kuwabara, N., Iwai, T., Uchida, J., Teramoto, K., Kaneda, N., Yukimura, T., Komiya, T., Nakatani, T., Miura, K. (2006) Molecular mechanisms and therapeutic strategies of chronic renal injury: the role of nuclear factor _B activation in the development of renal fibrosis. J. Pharmacol. Sci. 100, 17-21
5. Ito, S., Higuchi, Y., Yagi, Y., Nishijima, F., Yamato, H., Ishii, H., Osaka, M., Yoshida, M. (2013) Reduction of indoxyl sulfate by AST- 120 attenuates monocyte inflammation related to chronic kidney disease. J. Leukoc. Biol. 93, Epub ahead of print.
6. Hatakeyama, S., Yamamoto, H., Okamoto, A., Imanishi, K., Tokui, N., Okamoto, T., Suzuki, Y., Sugiyama, N., Imai, A., Kudo, S., Yoneyama, T., Hashimoto, Y., Koie, T., Kaminura, N., Saitoh, H., Funyu, T., Ohyama, C. (2012) Effect of an oral adsorbent, AST- 120, on dialysis initiation and survival in patients with chronic kidney disease. Int. J. Nephrol. 2012, 376128
7. Schulman, G., Beck, G. J., Remuzzi, G., Ritz, E., EPPIC (Evaluating Prevention of Progression in Chronic Kidney Disease) (2012) Results from 2 phase III, randomized, placebocontrolled, double-blind trials of AST-120 in adults with CKD. J. Am. Soc. Nephrol. 23, SA-PO1106 (abs.).
8. Lekawanvijit, S., Kompa, A. R., Manabe, M., Wang, B. H., Langham, R. G., Nishijima, F., Kelly, D. J., Krum, H. (2012) Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a nondialysable uremic toxin, indoxyl sulfate. PLoS One 7, e41281
9. Lin, C. J., Chen, H. H., Pan, C. F., Chuang, C. K., Wang, T. J., Sun, F. J., Wu, C. J. (2011) p-Cresylsulfate and indoxyl sulfate level at different stages of chronic kidney disease. J. Clin. Lab. Anal. 25, 191-197
10. Wu, I. W., Hsu, K. H., Lee, C. C., Sun, C. Y., Hsu, H. J., Tsai, C. J., Tzen, C. Y., Wang, Y. C., Lin, C. Y., Wu, M. S. (2011) p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease. Nephrol. Dial. Transplant. 26, 938-947.